Standout Papers

Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus 2002 2026 2010 2018 604
  1. Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus (2002)
    Giancarlo Viberti, Nigel Wheeldon Circulation

Citation Impact

2 by Nobel laureates 5 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

From nature to industry: Harnessing enzymes for biocatalysis
2023 StandoutScience
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
2 intermediate papers

Works of Nigel Wheeldon being referenced

Globotriaosylsphingosine (Lyso‐Gb3) as a biomarker for cardiac variant (N215S) Fabry disease
2018
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus
2002 Standout

Author Peers

Author CCM Surgery Epidemiology EDM Nephrology Last Decade Papers Cites
Nigel Wheeldon 1031 211 107 362 229 40 1.5k
Xiaolun Sun 3 137
Xiaoming Liang 11 39 1 21 340
E. J. Vanagt 325 43 9 1 15 366
V. Pantić 1 2 3 63 8 39 282
Fabio Rotondi 7 261 13 18 319

All Works

Loading papers...

Rankless by CCL
2026